Skip to content

Up2info.com

News / Analytics / Reviews

  • Stock Market Analysis
  • Corporate News
  • Financial News

Tag: SAVA

Cassava says DoJ has ended probe into research misconduct

Cassava Sciences (SAVA) announced on Thursday that the Fraud Section of the U.S. Department of Justice has closed an...

wpadmin
February 19, 2026

Cassava Sciences to pay $31.25M to settle securities class action suit

Cassava Sciences (SAVA) announced on Tuesday that it agreed to pay $31.25M to settle a class action lawsuit pending in a...

wpadmin
December 23, 2025

Cassava Sciences drops on delay for epilepsy study

Cassava Sciences (SAVA) fell ~14% in the premarket on Friday after the company said it will be forced to delay a clinical...

wpadmin
December 19, 2025

Cassava Sciences hit with FDA request for more data on simufilam trial

Cassava Sciences (SAVA) said in a filing the FDA has asked for more information before allowing its investigational new...

wpadmin
December 3, 2025

Cassava Sciences rises 10% after market close on CEO stock buy

Cassava Sciences has popped 10% in after-market-close trading Monday following an SEC filing indicated that CEO Richard...

wpadmin
November 24, 2025

Cassava Sciences spikes as CEO buys stock

Shares of Cassava Sciences (SAVA) added ~5% in the premarket on Friday after Richard Barry, President and Chief Executive...

wpadmin
November 21, 2025

Cassava Sciences files $200M mixed securities shelf

Cassava Sciences (SAVA) has filed a shelf registration statement with the SEC to offer up to $200 million worth of mixed...

wpadmin
November 13, 2025

Cassava says court dismisses criminal case against scientist

Cassava Sciences (NASDAQ:SAVA) shares rose as much as 6% premarket on Friday after a U.S. court dismissed a criminal case...

wpadmin
October 24, 2025

Cassava Sciences CEO buys $534K in company stock

Cassava Sciences (NASDAQ:SAVA) president & CEO Richard Barry has disclosed a purchase of 237,941 shares of the...

wpadmin
September 23, 2025

Cassava Sciences GAAP EPS of -$0.92

Cassava Sciences press release (NASDAQ:SAVA): Q2 GAAP EPS of -$0.92. Cash and cash equivalents were $112.4 million, with no...

wpadmin
August 14, 2025

Posts navigation

Older posts

Powered By WordPress | Newsmagify